Replies to post #158887 on Elite Pharmaceuticals Inc (ELTP)

[mrwrn2010]

Haha and there it is. ELI-200 > Hysingla.

[sharkey1]

Thanks weez, for the refresher, one has to read into that to see exactly what they are saying, almost a double negative, and I bought back in b-4 last nov.s CC, because of that P/R

[Couch]

Let the ADF WARS begin!!!

Eli 200 vs Hysingla

Winner and still CHAMPION = Eli 200

http://www.marketwatch.com/story/elite-pharmaceuticals-releases-positive-top-line-human-abuse-liability-data-for-eli-200-an-opioid-abuse-deterrent-product-2014-09-09

1) ELI 200

The study results demonstrated statistically significant (p <.0001) lower measures of drug liking, drug high and good drug effects for Elite's manipulated (crushed) ELI-200 when compared to the manipulated (crushed) drug listed comparator product and found 91.9% of the subjects experienced increased drug liking with the comparator product compared to ELI-200 in non-dependent recreational drug users when administered intranasally.

VS

2) HYSINGLA

http://www.purduepharma.com/wp-content/uploads/hysinglaerpi.pdf

Approximately 80% (n = 20) of subjects had some reduction in drug liking with tampered HYSINGLA ER relative to hydrocodone powder.

[kayak_wench]

An informative post, that succinctly addressed another poster's request, and presents facts that are relevant to the long-term viability of this stock.

Awesome!

[dr_lowenstein]

LOL OH MY!! surely I need not have to remind you of the statistical and clinical invalidity of such cross study comparisons. Different drugs, different testing procedures etc make such comparisons worthless. Thanks though